Abstract
The characteristic reciprocal translocations in Burkitt’s lymphomas (BL) always involve the c-myc proto-oncogene on chromosome 8 and one of the immunoglobulin (Ig) loci on chromosomes 2, 14, or 22. The breakpoints relative to both c-myc and the immunoglobulin genes vary considerably and may be located either within the c-myc transcription unit or up to several hundred kilobases 5′ or 3′ of c-myc. The translocated c-myc allele in BL cells displays several characteristic features: (i) c-myc is predominantly expressed from the translocation chromosome, whereas the normal allele is transcriptionally silent or expressed at low level only, (ii) structural alterations occur consistently in and around c-myc exon 1, (iii) the block to RNA elongation is functionally missing, and (iv) the P1 promoter is the preferential site of transcriptional initiation, in contrast to the normal c-myc gene where 80–90% of total c-myc RNA is derived from the P2 promoter (promoter shift) (Taub et al., 1984a,b; Yang et al., 1985; Bornkamm et al., 1988; Nishikura and Murray, 1988; Spencer and Groudine, 1991)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Atchison, M.L. and Perry, R.P. (1987). The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription. Cel 48, 121–128.
Atchison, M.L. and Perry, R.P. (1988). Complementation between two cell lines lacking kappa enhancer activity: implications for the developmental control of immunoglobulin transcription. EMBO J. 7, 4213–4220.
Blasquez, V.C., Xu, M., Moses, S.C., and Garrard, W.T. (1989). Immunoglobulin kappa gene expression after stable integration. I. Role of the intronic MAR and enhancer in plasmacytoma cells. J. Biol. Chem. 264, 21183–21189.
Blasquez, V.C., Hale, M.A., Trevorrow, K.W., and Garrard, W.T. (1992). Immunoglobulin kappa gene enhancers synergistically activate gene expression but independently determine chromatin structure. J. Biol. Chem. 267, 23888–23893.
Bornkamm, G.W., Polack, A., and Eick, D. (1988). c-myc deregulation by chromosomal translocation in Burkitt’s lymphoma. In Cellular oncogene activation. G. Klein, ed. (New York, Basel: Dekker,M.,lnc. ), pp. 223–273.
Cockerill, P.N. and Garrard, W.T. (1986). Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell 44, 273–282.
Cory, S. (1986). Activation of cellular oncogenes in Hemopoietic cells by chromosome translocation. Adv. Cancer Res. 47, 189–234.
Henglein, B., Synovzik, H., Groitl, P., Bornkamm, G.W., Hartl, P., and Lipp, M. (1989). Three breakpoints of variant t(2;8) translocations in Burkitt’s lymphoma cells fall within a region 140 kilobases distal from c-myc. Mol. Cell. Biol. 9, 2105–2113.
Judde, J.-G. and Max, E.E. (1992). Characterization of the human immunoglobulin kappa gene 3’ enhancer: Functional importance of three motifs that demonstrate B- cell-specific in vivo footprints. Mol. Cell. Biol. 72, 5206–5216.
Magrath, I. (1990). The pathogenesis of Burkitt’s lymphoma. Adv. Cancer Res. 55, 134–270.
Meyer, K.B. and Neuberger, M.S. (1989). The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region. EMBO J. 6, 1959–1964.
Nishikura, K. and Murray, J.M. (1988). The mechanism of inactivation of the normal c-myc gene locus in human Burkitt lymphoma cells. Oncogene 2, 493–498.
Picard, D. and Schaffner, W. (1984). A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene. Nature 307, 80–82.
Polack, A., Strobl, L., Feederle, R., Schweizer, M., Koch, E., Eick, D., Wiegand, H., and Bornkamm, G.W. (1991). The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt specific promoter shift. Oncogene 6, 2033–2040.
Pongubala, J.M. and Atchison, M.L. (1991). Functional characterization of the developmentally controlled immunoglobulin kappa 3′ enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors. Mol. Cell Biol. 11, 1040–1047.
Richman, A. and Hayday, A. (1989). Normal expression of a rearranged and mutated c-myc oncogene after transfection into fibroblasts. Science 246, 494–497.
Richman, A. and Hayday, A. (1989). Serum-inducible expression of transfected human c-myc genes. Mol. Cell. Biol. 9, 4962–4969.
Sen, R. and Baltimore, D. (1989). Factors regulating immunoglobulin-gene transcription. In Imunoglobulin Genes. T. Honjo, F.W. Alt, and T.H. Rabbitts, eds. ( London: Academic Press ), pp. 327–342.
Siebenlist, U., Hennighausen, L., Battey, J., and Leder, P. (1984). Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell 37, 381–391.
Siebenlist, U., Bressler, P., and Kelly, K. (1988). Two distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL60 cells. Mol. Cell. Biol. 3, 867–874.
Spencer, C.A., LeStrange, R.C., Novak, U., Hayward, W.S., and Groudine, M. (1990). The block to transcription elongation is promoter dependent in normal and Burkitt’s lymphoma c-myc alleles. Genes Dev. 4, 75–88.
Taub, R., Moulding, C., Battey, J., Murphy, W., Vasicek, T., Lenoir, G.M., and Leder, P. (1984). Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells. Cell 36, 339–348.
Taub, R., Kelly, K., Battey, J., Latt, S., Lenoir, G.M., Tantravahi, U.T., and Leder, P. (1984). A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma. Cell 37, 511–520.
Yang, J.-Q., Bauer, S., Mushinski, J.F., and Marcu, K.B. (1985). Chromosome translocations clusterd 5% of the murine c-myc qualitatively affect promoter usage: implications for the site of normal c-myc regulation. EMBO J. 4, 1441–1447.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hörtnagel, K., Polack, A., Mautner, J., Feederle, R., Bornkamm, G.W. (1995). Regulatory Elements in the Immunoglobulin Kappa Locus Induce c-myc Activation in Burkitt’s Lymphoma Cells. In: Potter, M., Melchers, F. (eds) Mechanisms in B-Cell Neoplasia 1994. Current Topics in Microbiology and Immunology, vol 194. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79275-5_48
Download citation
DOI: https://doi.org/10.1007/978-3-642-79275-5_48
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79277-9
Online ISBN: 978-3-642-79275-5
eBook Packages: Springer Book Archive